title: [Analysis of the use of prostate specific antigen (PSA) in a health area of the Community of Madrid].
abstract: OBJECTIVE
  To approach the local extent of PSA-use, and to check its yield in terms of prostate cancer (PC) detection.
  
  
  METHODS
  All PSA-test records (1997-1999) were reviewed and testing rates calculated per 1000 person-years. Detection rate (PC) was also estimated and referred to our PC prevalence study using the odds ratio as instrument for comparison.
  
  
  RESULTS
  Testing rate in the general population was 21.6/1000 person-years. PC detection rate was 1.76% (1.28 inside the prevalence study). For every CP detected in the general population with a PSA ranging 4-10 ng/ml, 2.39 (OR = 2.39) were detected in the prevalence study (OR = 4.48 for the PSA range > 10 ng/ml).
  
  
  CONCLUSIONS
  PSA-testing in our setting is high. PC detection rates were lower than expected.
authors.affiliation: Servicio de Urología, Hospital Universitario de Getafe, Madrid.
authors.forename: A
authors.initials: A
authors.lastname: Páez Borda
authors.forename: M
authors.initials: M
authors.lastname: Luján Galán
authors.forename: L
authors.initials: L
authors.lastname: Llanes González
authors.forename: I
authors.initials: I
authors.lastname: Romero Cagigal
authors.forename: M A
authors.initials: MA
authors.lastname: de la Cal López
authors.forename: E
authors.initials: E
authors.lastname: Miravalles González
authors.forename: A
authors.initials: A
authors.lastname: Berenguer Sánchez
mesh_terms: D000368:Aged; D006801:Humans; D008297:Male; D008875:Middle Aged; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood*; D013030:Spain; D014504:Urban Health
chemical_list: D017430:Prostate-Specific Antigen